Triglycidyl isocyanurate (TGIC; Teroxirone) is a triazene triepoxide with antiangiogenic and antineoplastic activities. It inhibits the growth of non-small-cell-lung cancer cells via p53 activation, induces cell apoptosis, and can be used for cancer research.
- Reduces spheroid growth of human non-small-cell-lung cancer cells in culture.
- Inhibits akt1/2/3 expression and phosphorylated Aktser473/474/472 in tumorspheres.
- Cleavage of PARP and procaspase-3, with emergent active caspase-3 fragment, are visible in H460 and A549 tumorspheres.
- Suppresses xenograft tumor growth in nude mice without affecting weight.